LBO France et al. lead Bioserenity's €15m series-A

LBO France provided capital through its venture and growth capital vehicle, Sisa. The deal is the ninth investment for the GP's fund, while BPI France deployed capital from its PSIM fund.

The current funding round will allow the company to boost its internationalisation and industrialisation efforts, according to a statement. The business recently opened several new offices in France, China and the US.

Company
Founded in 2014 and headquartered in Paris, Bioserenity develops devices that aim to facilitate the diagnosis and monitoring of patients, as well as calibrate their treatments. The company focuses on four pathological areas: epilepsy, cardiovascular diseases, pregnancy monitoring and sleep disorders.

The business has 80 employees.

People
LBO France – Valéry Huot (partner).
BPI France – Emmanuel Audouard (director).
Idinvest Partners – Luc Maruenda (partner).
Bioserenity – Pierre Frouin (founder, CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• Healthcare
• France
• Venture
• LBO France
• IDInvest Partners (AGF Private Equity)
• BPI France